Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.98 USD | +2.44% |
|
+9.88% | +14.76% |
01/07 | Syndax Pharmaceuticals, Inc.(NasdaqGS:SNDX) dropped from Russell 3000 Value Index | CI |
01/07 | Syndax Pharmaceuticals, Inc.(NasdaqGS:SNDX) dropped from Russell 2500 Value Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.76% | 207.2Cr | |
+23.69% | 4.66TCr | |
+44.87% | 4.17TCr | |
-0.84% | 4.12TCr | |
+34.87% | 3.24TCr | |
+21.10% | 2.82TCr | |
-6.35% | 2.81TCr | |
+49.42% | 1.45TCr | |
+47.93% | 1.37TCr | |
+0.49% | 1.22TCr |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- Transcript : Syndax Pharmaceuticals, Inc. Presents at B. Riley Securities' 3rd Annual Oncology Conference, Jan-19-2023 10